摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)-4'',6''-O-isopropylidene]glucosyl-4H-chromen-4-one | 1246840-52-7

中文名称
——
中文别名
——
英文名称
5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)-4'',6''-O-isopropylidene]glucosyl-4H-chromen-4-one
英文别名
5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-4,6-O-isopropylidene-2-(3',4'-dihydroxyphenyl)-3-β-D-(2'',3''-di-p-flurobenzyloxy)glucosyl-4H-chromen-4-one
5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)-4'',6''-O-isopropylidene]glucosyl-4H-chromen-4-one化学式
CAS
1246840-52-7
化学式
C67H54F2O14
mdl
——
分子量
1121.15
InChiKey
ZGLHPHVMSJXIPN-CVHFPNGMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    12.13
  • 重原子数:
    83.0
  • 可旋转键数:
    17.0
  • 环数:
    12.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    156.65
  • 氢给体数:
    0.0
  • 氢受体数:
    14.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)-4'',6''-O-isopropylidene]glucosyl-4H-chromen-4-one盐酸 作用下, 以 四氢呋喃甲醇 为溶剂, 以75%的产率得到5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)]glucosyl-4H-chromen-4-one
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents
    摘要:
    A series of novel quercetin diacylglucosides were designed and first synthesized by Steglich esterification on the basis of MRSA strains inhibiting natural compound A. The in vitro inhibition of different multidrug resistant bacterial strains and Escherichia coli DNA gyrase B was investigated. In the series, compound 10h was up to 128-fold more potent against vancomycin-resistant enterococci and more effective than A, which represents a promising new candidate as a potent anti-MRSA and anti-VRE agent. (C) 2010 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2010.02.060
  • 作为产物:
    描述:
    5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-(4'',6''-O-isopropylidene)glucosyl-4H-chromen-4-one4-氟苯乙酸4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 以70%的产率得到5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',3''-di-O-(4-fluorophenylacetyl)-4'',6''-O-isopropylidene]glucosyl-4H-chromen-4-one
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents
    摘要:
    A series of novel quercetin diacylglucosides were designed and first synthesized by Steglich esterification on the basis of MRSA strains inhibiting natural compound A. The in vitro inhibition of different multidrug resistant bacterial strains and Escherichia coli DNA gyrase B was investigated. In the series, compound 10h was up to 128-fold more potent against vancomycin-resistant enterococci and more effective than A, which represents a promising new candidate as a potent anti-MRSA and anti-VRE agent. (C) 2010 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2010.02.060
点击查看最新优质反应信息